Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Bladder cancer recurrent
ADR ID BADD_A06949
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.08      Renal and urinary tract neoplasms malignant and unspecified
16.08.01      Bladder neoplasms malignant
16.08.01.003      Bladder cancer recurrent
20      Renal and urinary disorders
20.03      Bladder and bladder neck disorders (excl calculi)
20.03.04      Bladder neoplasms
20.03.04.005      Bladder cancer recurrent
Description Not Available
MedDRA Code 10005005
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Bladder cancer recurrent | Bladder carcinoma recurrent | Ca bladder recurrent | Carcinoma bladder recurrent | Carcinoma urinary bladder recurrent | Malignant neoplasm of anterior wall of urinary bladder recurrent | Malignant neoplasm of bladder neck recurrent | Malignant neoplasm of bladder recurrent | Malignant neoplasm of bladder, part unspecified recurrent | Malignant neoplasm of dome of urinary bladder recurrent | Malignant neoplasm of lateral wall of urinary bladder recurrent | Malignant neoplasm of other specified sites of bladder recurrent | Malignant neoplasm of posterior wall of urinary bladder recurrent | Malignant neoplasm of trigone of urinary bladder recurrent | Malignant neoplasm of urachus recurrent | Malignant neoplasm of ureteric orifice recurrent | Urinary bladder carcinoma recurrent
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00551Cyclosporine0.000111%
BADD_D00563Dabigatran0.000367%
BADD_D00578Dapagliflozin0.000219%
BADD_D00765Empagliflozin0.000091%
BADD_D01253Lenalidomide0.000362%
BADD_D01777Pioglitazone0.000429%
BADD_D01913Ranitidine0.000038%
BADD_D02330Valrubicin0.000112%
BADD_D02586Radium ra-223 dichloride-
The 1th Page    1    Total 1 Pages